Loading...
Market
CVS Health stock price movement by end of 2024 compared to October 18, 2024?
2
Resolution / Starting Odds
Higher • 25%
Lower • 25%
Unchanged (+/- 5%) • 25%
Other • 25%
Stock market data from a reliable financial information provider
Story
CVS Replaces CEO Karen Lynch with David Joyner, Lowers Earnings Forecast, Withdraws 2024 Guidance
Oct 18, 2024, 11:38 AM
CVS Health has appointed David Joyner as its new President and Chief Executive Officer, succeeding Karen Lynch, who stepped down after an agreement with the board. The leadership change comes as the company struggles to drive higher profits and stock performance. CVS issued a profit warning, expecting preliminary third-quarter adjusted earnings per share (EPS) between $1.05 and $1.10, significantly below analysts' estimates of $1.70. The company also reported a higher medical loss ratio of 95%, exceeding expectations of 91%, and withdrew its most recent 2024 guidance issued in August. In response, CVS shares tumbled over 13% in pre-market trading.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Outperforms Walgreens • 25%
Underperforms Walgreens • 25%
Outperforms Cigna • 25%
Underperforms Cigna • 25%
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly Underperform • 25%
Below $1.00 • 25%
$1.00 to $1.10 • 25%
$1.11 to $1.20 • 25%
Above $1.20 • 25%
Increase by more than 5% • 25%
Increase by up to 5% • 25%
Decrease by up to 5% • 25%
Decrease by more than 5% • 25%